RA
Strides Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Biosimilar Adalimumab | Autoimmune Diseases (e.g., Rheumatoid Arthritis) | Development |
| Biosimilar Bevacizumab | Oncology (Various Cancers) | Development |
| Biosimilar Trastuzumab | Oncology (HER2+ Breast Cancer) | Development |
| Biosimilar Pegfilgrastim | Oncology (Neutropenia) | Development |
| Complex Generic Portfolio | Various (CNS, CVS, Anti-infectives) | ANDA Filed/Approved |
| Starflu (Oseltamivir) | Influenza | Marketed |
| HIV/AIDS, TB, Malaria Portfolio | Infectious Diseases | Marketed |